These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 4533361

  • 1. Blood histamine in the differential diagnosis of myeloid splenomegaly (osteomyelofibrosis) and other myeloproliferative disorders.
    Gingold N.
    Rev Roum Med; 1974; 12(1):15-8. PubMed ID: 4533361
    [No Abstract] [Full Text] [Related]

  • 2. [Granulocyte clearance and granulocyte kinetics in myeloproliferative syndromes].
    Jungi WF, Meuret G, Senn HJ.
    Schweiz Med Wochenschr; 1974 Jan 26; 104(4):133-5. PubMed ID: 4521299
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [On the existence of a myeloproliferative factor in patients with a myeloproliferative syndrome (author's transl)].
    Essers U, Nowak H.
    Blut; 1979 Aug 26; 39(2):107-15. PubMed ID: 289427
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phagocytosis in myeloproliferative disorders.
    Corberand J, LaHarrague P, De Larrard B, Nguyen F, Pris J.
    Am J Clin Pathol; 1980 Sep 26; 74(3):301-5. PubMed ID: 6932175
    [Abstract] [Full Text] [Related]

  • 12. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
    Brodsky I, Kahn SB, Ross EM, Petkov G.
    Cancer; 1972 Dec 26; 30(6):1444-50. PubMed ID: 4509103
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Characteristics of the morphology and function of the thrombocytes in myeloproliferative diseases].
    Petrov MN, Vashkinel' VK.
    Probl Gematol Pereliv Krovi; 1977 May 26; 22(5):18-23. PubMed ID: 267283
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Hemostasis disorders with reduced activity of the von Willebrand factor in myeloproliferative syndromes].
    Leupin L, Beck EA, Furlan M, Bucher U.
    Schweiz Med Wochenschr; 1983 May 14; 113(19):713-6. PubMed ID: 6603016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.